Think Tank Series: Diversity and Health Equity in Clinical Trials: Expert Panel Insights


Think Tank Series: Diversity and Health Equity in Clinical Trials: Expert Panel Insights Banner



Date & Location
Tuesday, February 20, 2024, 12:00 AM - Friday, February 19, 2027, 11:59 PM, On Demand

Overview

The objective of this summit is to bridge connections between stakeholders to engage in thought-provoking and meaningful discussion that addresses the current lack of diversity in clinical trials. Through these synergies, we aim to propose effective and innovative recommendations that can improve the enrollment of underrepresented participant populations and advance the science of diversity in clinical trials.

In this video, panelists at the Stanford Think Tank on Diversity and Health Equity in Clinical Trials share their expertise on improving healthcare research through diversity and inclusion. We bring together insightful discussions from our expert panel on various aspects of promoting diversity and health equity in clinical trials.

PANELISTS: Andra Blomkalns, MD | Moderator

Ruth O'Hara, PhD

Harriet Van Spall, MD, MPH

Keith Norris, MD
Registration

  Release Date: April 2, 2024
  Expiration Date: April 1, 2027
  Estimated Time to Complete: 1.0 hour and 3 minutes
  Registration Fee: FREE

Click Begin (at the top) to launch the activity.



Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Participation Credit (1.00 hours)

Target Audience
Specialties - Non-clinical

Objectives
At the conclusion of this activity, learners should be able to:

  1. Describe the needs and identify the barriers to recruiting participants from underrepresented groups in clinical trials.
  2. Implement effective and innovative recommendations for improving the enrollment of participants from underrepresented groups in clinical trials.
  3. Determine how we define diversity for the future of clinical trials, including people with disabilities.
  4. Discuss the significance of diversity in clinical trials and its direct impact on healthcare outcomes.

Accreditation

Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 CreditsTM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  


Additional Information

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography

Bilyeu, J. P., Turner, K. L., Taylor, M. L., Mills, A. M., Sheppard, K., & Housley, B. A. (2023). Improving interprofessional practice and cultural competence with a DEI-focused IPE event. Health Interprofessional Practice and Education, 7(2). https://doi.org/10.61406/hipe.299

View references.



For activity related questions, please contact
     Name: Latha Palaniappan, MD, MS
     Title: Professor of Medicine (Cardiovascular Medicine) and, By Courtesy, of Epidemiology and Population Health
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]